Recruiting
Neck pain
RecruitingRegistered drug
Study on Chiropractic Therapy and Ibuprofen for Acute Neck Pain in Adults
Registered drug
Countries:
Norway
Norway- Participants:18–64 years
- Substances:Ibuprofen
- Sponsor:Akershus University Hospital
Back to NorwayClinical trials in Oslo – page 15
527 clinical trials in Oslo, Norway across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)Oslo at a glance
527
clinical trials
- Research sites9
Recruiting
Myelodysplastic syndrome
RecruitingRegistered drugNo placebo
Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation
Registered drugNo placebo
- Disease:Myelodysplastic syndrome
- Substances:Azacitidine
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Azacitidine
- Sponsor:Karolinska University Hospital
Recruiting
Neoplasm
RecruitingInvestigationalNo placebo
Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion
InvestigationalNo placebo
- Disease:Neoplasm
- Substances:Zenocutuzumab
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Zenocutuzumab
- Sponsor:Partner Therapeutics Inc.
Recruiting
Glioblastoma
RecruitingRegistered drugNo placebo
Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients
Registered drugNo placebo
- Disease:Glioblastoma
- Substances:Temozolomide
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Temozolomide
- Sponsor:Region Oestergoetland
Recruiting
Non-Hodgkin's lymphoma
RecruitingRegistered drugNo placebo
Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase
Registered drugNo placebo
- Disease:Non-Hodgkin's lymphoma
- Substances:CyclophosphamideCytarabine+11
Countries:Norway
Norway- Participants:0–17 years
- Substances:Cyclophosphamide
- Sponsor:Universitaetsklinikum Muenster AöR
Recruiting
Factor VIII deficiency
RecruitingRegistered drugNo placebo
Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa
Registered drugNo placebo
- Disease:Factor VIII deficiency
- Substances:Efanesoctocog Alfa
Countries:Norway
Norway- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Efanesoctocog Alfa
- Sponsor:Swedish Orphan Biovitrum AB (publ)
Recruiting
Rectal cancer recurrent
RecruitingRegistered drugNo placebo
Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer
Registered drugNo placebo
- Disease:Rectal cancer recurrent
- Substances:CapecitabineFluorouracil+6
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Capecitabine
- Sponsor:Catharina Ziekenhuis Stichting
Recruiting
Osteochondrodysplasia
RecruitingInvestigational
Study on the Safety and Effectiveness of TransCon CNP for Infants with Achondroplasia
Investigational
- Disease:Osteochondrodysplasia
- Substances:–
Countries:Norway
Norway- Participants:0–17 years
- Sponsor:Ascendis Pharma Growth Disorders A/S
Recruiting
Metastases to peritoneum
RecruitingInvestigationalNo placebo
Study of Radium-224 in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer with Peritoneal Metastasis Undergoing Chemotherapy and Surgery
InvestigationalNo placebo
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Radium-224 Adsorbed In Calcium Carbonate Microparticles
- Sponsor:Oncoinvent Solutions AS
Recruiting
Rheumatoid arthritis
RecruitingRegistered drugNo placebo
Study on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis
Registered drugNo placebo
- Disease:Rheumatoid arthritis
- Substances:Methotrexate
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Methotrexate
- Sponsor:Diakonhjemmet Sykehus AS
Recruiting
Malignant melanoma stage III
RecruitingInvestigationalNo placebo
Study of LTX-315 and Pembrolizumab for Patients with Resectable Stage III-IV Melanoma
InvestigationalNo placebo
- Disease:Malignant melanoma stage III
- Substances:Ruxotemitide
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Ruxotemitide
- Sponsor:Oslo University Hospital HF
Recruiting
Metastases to liver+1
RecruitingRegistered drugNo placebo
Study on Melphalan, Ipilimumab, and Nivolumab for Patients with Uveal Melanoma Liver Metastases
Registered drugNo placebo
- Disease:Metastases to liverUveal melanoma
- Substances:IpilimumabNivolumab
Countries:Norway
Norway- Participants:18–64 years · 65+ years
- Substances:Ipilimumab
- Sponsor:Vaestra Goetalandsregionen
Other cities in Norway
The busiest research cities in the country
Clinical research in Oslo
What the registry says about research in the country
01 Respiratory Medicine
Clinical trials focusing on pulmonary conditions and respiratory health, including studies on idiopathic pulmonary fibrosis and respiratory syncytial virus prevention in children.
- IPF Treatment Evaluation
- RSV Prevention Studies
- Chronic Wet Cough Research
Innovative therapies being tested to improve lung function and patient outcomes.
02 Cardiovascular Research
Studies examining heart conditions and vascular health, with particular focus on heart failure and cardiovascular disease prevention.
- Heart Failure Imaging Studies
- Cardiovascular Disease Prevention
- Hypovolemia Management
Advanced imaging techniques and therapeutic interventions being evaluated for cardiac conditions.
03 Oncology Studies
Comprehensive research into various cancer treatments, including trials for gastric, esophageal, and rare cancers.
- Advanced Solid Tumors
- Targeted Cancer Therapies
- Multiple Myeloma Treatment
Novel therapeutic approaches combining immunotherapy with conventional treatments.